[ad_1]
AstraZeneca COVID-19 vaccine is used at the injection site.
The notice from the European Medicines Administration (EMA), issued by Vietnam’s Ministry of Health this afternoon 12-3, said that EMA has received a report that Denmark suspends the use of AstraZeneca’s COVID-19 vaccine in the program of vaccination was due to a documented complication of thromboembolism in some of the vaccinated people, 1 fatal.
Several other EU countries have made similar decisions.
According to information from the Ministry of Health Online youthSo far, 7 countries have made this decision.
According to the EMA, as of March 10, 30 cases of thromboembolic complications were reported among the nearly 5 million people vaccinated in the EEA.
The EMA also believes that there have been no signs that vaccination caused the disease.
In Vietnam, on the morning of March 12, 9 provinces used the AstraZeneca vaccine to organize vaccination, with almost 1,600 people vaccinated. This number will increase as more vaccines become available in Vietnam with a total of more than 5 million doses between now and April.
After 4 days of vaccination with the AstraZeneca vaccine, the National Expanded Immunization Program has recorded that 9 people with post-vaccination reactions should be treated in the hospital, including 6 cases of anaphylactic reaction 2.
The usual reaction signs in cases of complications after injection in Vietnam are congestion, diarrhea, fever, some mild reactions such as pain at the injection site, restlessness, vomiting …
So far there have been no cases of thromboembolism among those who have been vaccinated in Vietnam.
The AstraZeneca vaccine has been approved for use in more than 25 countries, including Vietnam. Vietnam imported the first batch of vaccines on February 24 and was widely vaccinated on March 8. In the current situation, the Ministry of Health continues to organize vaccination with this vaccine.
Meanwhile, the EMA said that EU authorities are assessing complications of en bloc thromboembolism after injection and will report it as soon as there are new developments.
